Identifying Monogenic Diabetes Misdiagnosed as Type 1
Official title: Accurate Diagnosis of Diabetes for Appropriate Management
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT03988764 · Data updated 2026-11-12
This study is trying to find out how often young people are wrongly diagnosed with type 1 diabetes when they actually have a rare form called monogenic diabetes, by testing their blood and looking for specific genetic changes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Day to 25 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | September 24, 2019 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | December 10, 2024 |
| Trial ID | NCT03988764 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with diabetes under the age of 25 who have either type 1 diabetes or an undetermined type.
✕Probably not a fit
Patients with a positive result on existing T1D autoantibody testing will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to determine how often monogenic diabetes is misdiagnosed as type 1 diabetes (T1D) in individuals under 25 years old. It will recruit 5,000 participants from 17 clinics across Canada, testing them for specific autoantibodies and performing exome sequencing on those negative for all four antibodies. The study will analyze various clinical variables to develop a predictive algorithm for identifying monogenic diabetes cases. Additionally, it seeks to discover novel genetic mutations associated with monogenic diabetes that may have been overlooked.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses and tailored treatments for patients with monogenic diabetes.
How similar studies have gone: Other studies have shown success in identifying genetic causes of diabetes, but this specific approach to misdiagnosis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type. Exclusion Criteria: * Existing T1D autoantibody testing with a positive result
Where it's running
-
The Montreal Children's Hospital
Montreal, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Constantin Polychronakos, MD
- Email: constantin.polychronakos@mcgill.ca
- Phone: 5144124400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chinese monogenic diabetes registry
This project will test whether an online and mobile registry can find and genetically confirm people in China with monogenic forms of diabetes, including neonatal diabetes and MODY.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
Tirzepatide for type 1 diabetes patients who are overweight or obese
This study tests whether tirzepatide can affect stomach emptying in adults with type 1 diabetes and overweight or obesity.
-
Oral insulin vs. subcutaneous insulin in adults with type 1 diabetes
This study tests an oral insulin tablet (SCD0503) against subcutaneous insulin and placebo to see how it behaves in the blood and helps control blood sugar in adults with type 1 diabetes.
-
Genetic risk score and progression to insulin in type 1 diabetes
This study tests whether a genetic risk score can predict which people with type 1 diabetes will need insulin progression over three years.
-
Home-based use of an advanced hybrid closed-loop insulin pump with telemonitoring for adults with type 1 diabetes
This study tests whether starting an advanced hybrid closed-loop insulin pump at home, with online education and telemonitoring, is feasible and safe for adults with type 1 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.